Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.16 | 0.007 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |